4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-004504
CFO and Treasurer sold 50,000 shares at an average $71.45 ($3,572,556)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2021-01-15 | Sale | −14,801 | $70.10 | $1,037,535 | 985,199 | I |
| Krognes Steve E. CFO and Treasurer | 2021-01-15 | Sale | −12,981 | $70.96 | $921,158 | 972,218 | I |
| Krognes Steve E. CFO and Treasurer | 2021-01-15 | Sale | −8,071 | $71.99 | $581,047 | 964,147 | I |
| Krognes Steve E. CFO and Treasurer | 2021-01-15 | Sale | −14,147 | $73.01 | $1,032,816 | 950,000 | I |
| Open-market sales · 50,000 sh · avg $71.45 · $3,572,556 | |||||||
Loading xslF345X03/doc4.xml…